Dr. Parvin Peddi, MD
Claim this profileSaint John's Cancer Institute
Studies Breast Cancer
Studies Cancer
6 reported clinical trials
16 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER positive
HER2 negative
2Cancer
HER2 positive
ER positive
ER negative
Affiliated Hospitals
Clinical Trials Parvin Peddi, MD is currently running
Afuresertib + Fulvestrant
for Breast Cancer
This trial tests a combination of two drugs, afuresertib and fulvestrant, for patients with a specific type of breast cancer who haven't responded to other treatments. The drugs work together to block cancer cell growth by targeting different pathways. Fulvestrant is an effective drug used for treating hormone receptor-positive, HER2-negative advanced breast cancer, often in combination with other targeted therapies.
Recruiting1 award Phase 314 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
More about Parvin Peddi, MD
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Parvin Peddi, MD has experience with
- DPX-Survivac
- Letrozole
- Cyclophosphamide
- XRT 10Gy X2
- Afuresertib
- Trastuzumab Emtansine
Breakdown of trials Parvin Peddi, MD has run
Breast Cancer
Cancer
Brain Metastasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Parvin Peddi, MD specialize in?
Parvin Peddi, MD focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Parvin Peddi, MD currently recruiting for clinical trials?
Yes, Parvin Peddi, MD is currently recruiting for 5 clinical trials in Santa Monica California. If you're interested in participating, you should apply.
Are there any treatments that Parvin Peddi, MD has studied deeply?
Yes, Parvin Peddi, MD has studied treatments such as DPX-Survivac, Letrozole, Cyclophosphamide.
What is the best way to schedule an appointment with Parvin Peddi, MD?
Apply for one of the trials that Parvin Peddi, MD is conducting.
What is the office address of Parvin Peddi, MD?
The office of Parvin Peddi, MD is located at: Saint John's Cancer Institute, Santa Monica, California 90404 United States. This is the address for their practice at the Saint John's Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.